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Abstract Parkinson’s disease-associated LRRK2 kinase phosphorylates multiple Rab GTPases,
including Rab8A and Rab10. We show here that LRRK2 kinase interferes with primary cilia
formation in cultured cells, human LRRK2 G2019S iPS cells and in the cortex of LRRK2 R1441C
mice. Rab10 phosphorylation strengthens its intrinsic ability to block ciliogenesis by enhancing
binding to RILPL1. Importantly, the ability of LRRK2 to interfere with ciliogenesis requires both
Rab10 and RILPL1 proteins. Pathogenic LRRK2 influences the ability of cells to respond to cilia-
dependent, Hedgehog signaling as monitored by Gli1 transcriptional activation. Moreover,
cholinergic neurons in the striatum of LRRK2 R1441C mice show decreased ciliation, which will
decrease their ability to sense Sonic hedgehog in a neuro-protective circuit that supports
dopaminergic neurons. These data reveal a molecular pathway for regulating cilia function that
likely contributes to Parkinson’s disease-specific pathology.
Editorial note: This article has been through an editorial process in which the authors decide how
to respond to the issues raised during peer review. The Reviewing Editor’s assessment is that all
the issues have been addressed (see decision letter).
DOI: https://doi.org/10.7554/eLife.40202.001
Introduction
Although the cause of most Parkinson’s disease remains unknown, autosomal dominant mutations in
the leucine rich repeat kinase 2 (LRRK2) gene account for 1–2% of all cases (and 18% of cases in
those of Ashkenazi Jewish descent) and lead to activation of the LRRK2 kinase (Alessi and Sammler,
2018). Recent mass spectrometry efforts have revealed a subgroup of Rab GTPases as the primary
substrates of LRRK2 (Steger et al., 2016; Steger et al., 2017). Rab GTPases are master regulators
of all membrane trafficking events in eukaryotic cells (Wandinger-Ness and Zerial,
2014; Pfeffer, 2017). LRRK2 phosphorylation modifies the so-called switch 2 regions of Rab pro-
teins that report the identity of the bound nucleotide. Because cognate effector and regulatory pro-
teins interact with Rabs in a nucleotide-dependent manner via this motif, phosphorylation on the
switch two loop interferes with the ability of Rabs to bind to most of their partner proteins
(Steger et al., 2016). Given the importance of the LRRK2 kinase in familial Parkinson’s disease, there
is great interest in determining which Rab-dependent processes are most significantly impacted by
elevated LRRK2 kinase activity.
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We recently showed that Rab29 GTPase, localized on the Golgi, recruits the predominantly cyto-
plasmic LRRK2 onto membranes and activates it’s ability to phosphorylate downstream Rab8A and
Rab10 substrates (Purlyte et al., 2018; see also Liu et al., 2018). Although Rab8A and Rab10 have
distinct localizations and roles in different tissues, they (along with Rab29) have been implicated in
the process of ciliogenesis. Primary cilia are single, microtubule-based cellular projections on many
types of cells that are critical for developmental signaling via the Sonic hedgehog (Shh) pathway as
well as for G-protein coupled receptor signaling pathways; they are produced in tight coordination
with the cell cycle (Hilgendorf et al., 2016; Rohatgi et al., 2007; Yoshimura et al., 2007;
Nachury et al., 2007) showed that exogenous expression of Rab8A protein increased cilia length
significantly, consistent with Rab8A being a limiting component of cilia formation. Yoshimura et al.
(2007) also discovered that the basal body associated, Cenexin-3 protein binds Rab8A and relocates
to the primary cilium together with Rab8A upon serum starvation. Subsequent work has shown that
both Rab8A and its guanine nucleotide exchange factor, Rabin8, are needed in part, for so-called
BBSome function in ciliogenesis (Nachury et al., 2007; Kno¨dler et al., 2010; Westlake et al., 2011;
Feng et al., 2012) and also for the delivery of membrane vesicles to the growing cilium (Lu et al.,
2015). Rab10 is detected in association with primary cilia in cultured MDCK and LLC-PK1 kidney
cells and in rodent renal tubules (Babbey et al., 2010). Rab10 is also reported to be necessary for
axonal membrane trafficking and axonal elongation (Wang et al., 2011; Liu et al., 2013).
We show here that Rab8A and Rab10 have opposing roles in normal ciliogenesis. Unlike Rab8A,
Rab10 is a native suppressor of ciliogenesis, and upon LRRK2 phosphorylation, it binds preferentially
to RILPL1 (Rab interacting lysosomal protein-like 1) protein to further interfere with cilia formation.
These cilia modulatory events have important consequences in the brain where they influence the
ability of cholinergic neurons to generate cilia in the somatosensory cortex; loss of cilia will decrease
the ability of these neurons to respond to a Sonic hedgehog signal that triggers neuroprotective sig-
naling toward dopaminergic circuits (Gonzalez-Reyes et al., 2012).
Results
Rab8A increases while Rab10 inhibits cilia formation in A549 cells
To explore the relationship between primary cilia and two important LRRK2 substrates, we revisited
the contributions of Rab8A and Rab10 to primary cilia formation. Throughout the text, Rab8 will
refer to Rab8A unless otherwise indicated. Consistent with previous reports (Yoshimura et al.,
2007; Nachury et al., 2007; Feng et al., 2012; Kno¨dler et al., 2010; Sato et al., 2014;
Babbey et al., 2010), some of the total pool of Rab8A localized at the base and within primary cilia
(detected with anti-Arl13b antibody; Figure 1A). In contrast, a portion of the total pool of Rab10
localized only to the base of cilia in both hTERT-RPE as well as primary, antibody-panned, rat astro-
cyte cells (Figure 1A). To study the roles of Rab8A and Rab10 in primary cilia formation, the proteins
were knocked out of A549 cells using CRISPR-Cas9, and their depletions were confirmed by immu-
noblot (Figure 1—figure supplement 1). As shown previously, loss of Rab8A decreased significantly
the capacity of A549 or RPE cells to generate primary cilia (Figure 1B–D). Surprisingly, loss of Rab10
increased the percentage of cells that made primary cilia compared with parental wild type A549
and RPE cells (Figure 1B,C,E). Importantly, the effects of Rab8A or Rab10 knockout on primary cilia
formation were reversed upon re-expression of exogenous Rab8A or Rab10 wild type proteins
(Figure 1D,E; Rab10,~4 fold overexpressed and Rab8A,~10 fold): exogenous Rab8A stimulated
while Rab10 inhibited ciliogenesis in cells lacking these proteins. Note that RPE cells start at a higher
level of intrinsic ciliation (Figure 1C, right) and thus there is less possibility of enhancing ciliation in
this cell type.
Finally, to investigate the relationship between Rab8A ciliogenesis activation and Rab10 suppres-
sion, A549 cells lacking Rab8A were further depleted of Rab10 using a lentiviral shRNA. More than
90% of the endogenous Rab10 was depleted in these cells as seen by immunoblot (Figure 1—figure
supplement 1, right panel). Surprisingly, loss of both Rab8A and Rab10 from A549 cells reversed
the block of ciliogenesis observed in Rab8A KO cells (Figure 1F). Thus, Rab10 is a dominant sup-
pressor of cilia formation. Even though A549 Rab10 KO cells are significantly ciliated, exogenous
Rab8A even further increases ciliation in these cells (Figure 1G). Thus, Rab8A drives a Rab10-inde-
pendent pathway for cilia formation. Note that loss of either Rab10 or Rab8A does not change the
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Figure 1. Rab10 is a negative regulator of primary cilia formation. hTERT-RPE cells (Figure 1A, upper panels) or primary rat astrocytes (Figure 1A,
lower panels) were transfected with GFP-Rab8A (A, left) or GFP-Rab10 (A, right). 24 hr post transfection, cells were fixed and stained for primary cilia
using anti-Arl13b antibodies (red). Dotted boxes indicate areas that are magnified in the insets. Yellow indicates co-localization between GFP-Rabs
(green) and Arl13b (red). (B) A549 knock out cells lacking endogenous Rab10 (Rab10-KO) or Rab8A (Rab8-KO) were ciliated on glass coverslips and 48
Figure 1 continued on next page
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level of the other protein (Figure 1—figure supplement 1). In addition, Rab8 goes to the cilium in
Rab10KO cells, as in wild type cells.
Rab8A and Rab10 mutants cannot be used to mimic phosphorylation
Phosphorylation of Rab proteins by LRRK2 has been shown to interfere with their ability of to bind
to numerous, cognate effector proteins (Steger et al., 2016). Studies of protein phosphorylation
often utilize substrate mutants generated in the hope that they cannot be phosphorylated (T-to-A)
or alternatively, that they will mimic the phosphorylation state (T-to-E). Unfortunately, we were
unable to use such mutant Rab8A or Rab10 proteins as a series of functional and localization tests
showed that they are nonfunctional. The non-phosphorylatable, threonine to alanine (TA) mutations
in both Rab8A and Rab10 failed to reverse their respective ciliation phenotypes observed in knock-
out cells (Table 1), indicating that they are non-functional. Light microscopy of A549 cells expressing
these mutants showed that unlike wild type Rab8A protein, Rab8A-TA was more concentrated over
the Golgi and not seen in cilia; Rab8A-TE was more dispersed than the wild type protein and may
aggregate upon expression in HEK293T cells. Rab10-TE was much more concentrated on the Golgi
than the wild type protein and Rab10-TA was entirely cytosolic (Figure 2A), as confirmed by mem-
brane fractionation after expression in HEK293T cells (Figure 2B). In vitro experiments using biotin-
geranyl pyrophosphate as substrate confirmed that neither Rab8A-TE nor Rab10-TA mutants are
good substrates for Rab geranylgeranyl transferase (Figure 2C). Finally, unlike the phosphorylated
versions of Rab8A or Rab10 proteins (Steger et al., 2017), Rab8A-TE and Rab10-TE failed to show
enhanced interaction with GFP-RILPL1 protein (Figure 2—figure supplement 1). This is a very
important caution—the TA and TE mutants do not reflect the desired states and should not be used
in future experiments exploring the consequences of Rab8A and Rab10 phosphorylation.
Figure 1 continued
hr later fixed and stained for primary cilia Arl13b (green). (C) Quantitation of data shown in (B) for A549 cells and also RPE cells analyzed in parallel.
Error bars represent SEM from three experiments with >200 cells per condition in each experiment. (D,E) Rab8A-KO or Rab10-KO A549 cells were
infected with lentivirus to stably express wild type GFP-Rab8A or GFP-Rab10, respectively. Cells were ciliated on coverslips and stained for Arl13b. (D)
Quantitation of primary cilia in Rab8A-KO A549 cells stably expressing GFP-Rab8A-WT. (E) Quantitation of primary cilia in Rab10-KO A549 cells stably
expressing GFP-Rab10-WT. (F) Quantitation of primary cilia in Rab8A-KO A549 cells treated with Rab10 shRNA. (G) Quantitation of primary cilia in WT
and Rab10-KO A549 cells expressing GFP-Rab8A. Error bars represent SEM from three experiments with >200 cells per condition. *, p<0.05; **, p<0.01;
***. p<0.001; ns = not significant. Scale bars = 10 mm.
DOI: https://doi.org/10.7554/eLife.40202.002
The following figure supplement is available for figure 1:
Figure supplement 1. Documentation of Rab8A and Rab10 shRNA efficacy.
DOI: https://doi.org/10.7554/eLife.40202.003
Table 1. Summary of Rab8A and Rab10 phosphosite mutant protein properties
Rab
protein
Membrane
associated Localization
In vitro
prenylated
In/at base of
cilia
Rescue ciliation in knockout
cells
Bind RILPL1
strongly
Rab8A WT YES Perinuclear
Cilium
YES In/at base YES When
phosphorylated
Rab8A TA YES Golgi YES NO NO NO
Rab8A TE Aggregated? Golgi? NO NO NO POORLY
Rab10 WT YES Perinuclear
Cilium base
YES At base YES When
phosphorylated
Rab10 TA NO Cytosol NO NO NO NO
Rab10 TE YES Golgi YES NO NO
(dominant effect)
POORLY
DOI: https://doi.org/10.7554/eLife.40202.006
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Figure 2. Rab8A and Rab10 phospho-site mutants are non-functional proteins. (A) Rab8A-KO and Rab10-KO A549
cells were infected with lentivirus to stably express wild type (WT), phospho-mimetic (TE) or non-phosphorylatable
(TA) mutants of Rab8A and Rab10, respectively. 24 hr post transfection, cells were fixed and stained with anti-GFP.
(B) HEK293T cells were transfected with wild type (WT), T73E (TE) or T73A (TA) mutant GFP-Rab10 or GFP-Rab8A
as indicated. After 24 hr, cells were fractionated into membrane and cytosol and 50 mg membranes and the
equivalent volume of cytosol was immunoblotted using anti-GFP antibodies. Graph indicates the percent of total
Rab10 or Rab8A protein that was membrane associated. (C) In vitro prenylation measured using cytosol fractions
from (B), incubated for 4 hr with biotin-geranyl pyrophosphate at room temperature. The reaction was
immunoprecipitated with GFP binding protein-Sepharose and samples were immunoblotted for biotin using
Strepatavidin-Alexa 800 and anti-GFP.
DOI: https://doi.org/10.7554/eLife.40202.004
The following figure supplement is available for figure 2:
Figure 2 continued on next page
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Phosphorylated Rab10 clusters near peri-centriolar membranes
Rab10 is phosphorylated in cells transfected with LRRK2 kinase (Steger et al., 2016; Purlyte et al.,
2018). To identify the localization of both total and phospho-Rab10 (pRab10) by immuno-staining,
HeLa cells were co-transfected with the activated, pathogenic mutant LRRK2-R1441G and GFP-
Rab10. After 24 hr,~80% of cells expressing exogenous LRRK2 showed total Rab10 concentrated
over a perinuclear cluster (Figure 3A,B). Furthermore, labeling of LRRK2 expressing cells using a
commercial anti-phosphoT73 Rab10-specific antibody revealed pRab10 staining only in LRRK2 co-
expressing cells; the strongest pRab10 signal was also detected in the perinuclear region together
with total Rab10 staining (Figure 3C). pRab10 localized adjacent to centrioles labeled with Centrin-
3, and co-localized with perinuclear transferrin receptor (TfR)-containing membranes (Figure 3C). As
noted earlier, RILPL1 interacts preferentially with the phosphorylated forms of Rab8A and Rab10
(Steger et al., 2017); Figure 2—figure supplement 1). In HEK293T cells co-transfected with RILPL1-
GFP and LRRK2, the clustered pRab10 co-localized perfectly with RILPL1 in the peri-centriolar
region. This strong co-localization supports the conclusion that RILPL1 binds to pRab10 in cells.
RILPL1 regulates pRab10 localization
RILPL1 has been shown to associate with the mother centriole that becomes the basal body that
nucleates the primary cilium (Schaub and Stearns, 2013); RILPL1’s C-terminal half is needed for this
localization. We confirmed mother centriole localization of RILPL1 in A549 cells (Figure 3—figure
supplement 1); RILPL1-GFP co-localized with CEP164, a marker of the mother centriole. Previous
work also indicated that RILPL1 influences the removal of signaling receptors from primary cilia
(Schaub and Stearns, 2013). Primary cilia form in G1 of the cell cycle and disassemble before mito-
sis. In RPE cells that had been induced to form cilia by serum starvation, endogenous RILPL1 co-
localized with Rab10 at the base of primary cilia, identified by staining with anti-Arl13B antibodies
(Figure 4A). A similar localization was also seen in ciliated, primary rat astrocytes (Figure 4B).
When RILPL1 expression was decreased in HEK293T cells using a lentiviral shRNA, perinuclear
clustering of pRab10 decreased and that phenotype was corrected upon RILPL1-GFP expression
(Figure 4D). Indeed, perinuclear pRab10 clustering increased upon exogenous RILPL1 expression
(Figure 4D). Overexpression of the C-terminal half of RILPL1 (RILPL1-C-GFP) dispersed pRab10
localization, whereas expression of the N-terminal half (RILPL1-N-GFP) had the same effect as the
full length protein (Figure 4C,E). Previous work showed that overexpression of the RILPL1 C-terminal
half interferes with RILPL1 localization and this region localizes RILPL1 to the centriole and domi-
nantly blocks primary cilia formation (Schaub and Stearns, 2013). Altogether, these data suggest
that the RILPL1 N-terminus interacts with pRab10 in pericentriolar membranes; overexpression of
the C-terminus dominantly interferes with cilia formation, perhaps by competing for interactions that
localize pRab10 and RILPL1 to that cellular compartment. Nevertheless, even in the absence of
RILPL1, some pRab10 localized to the pericentriolar region. This may be due to association with the
related RILPL2 protein still present in these cells and/or to other proteins.
Similar results were obtained for pRab10 localization in A549 RILPL1 KO cells (created using
CRISPR-Cas9; protein loss was confirmed by immunoblot; Figure 4H). While LRRK2 transfected,
parental A549 cells displayed most pRab10 in a peri-nuclear cluster, RILPL1 KO A549 cells had a less
focused distribution of pRab10 and showed additional punctate structures in the cytosol (Figure 4F–
H). These data support the conclusion that RILPL1 enhances pRab10 clustering on pericentriolar
membranes.
RILPL1 suppresses cilia formation at the mother centriole
Knockout of RILPL1 in A549 cells increased the percentage of cells that contained primary cilia, and
the length of the cilia also increased (Figure 5A,B). This effect was abrogated upon expression of
exogenous RILPL1 (Figure 5C), indicating that exogenous RILPL1 suppresses primary cilia formation,
in wild type cells and in cells lacking RILPL1 protein. A similar inhibition of ciliogenesis was also
Figure 2 continued
Figure supplement 1. Phospho-site mutants of Rab8A and Rab10 bind RILPL1 poorly.
DOI: https://doi.org/10.7554/eLife.40202.005
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Figure 3. pRab10 localizes on peri-centriolar membranes. HeLa cells stably expressing GFP-Rab10 were
transfected with or without LRRK2-R1441G plasmid. After 24 hr, cells were fixed and stained with the indicated
antibodies. (A) Localization of total GFP-Rab10 (green) without (left) or with (right) R1441G-LRRK2 transfection. (B)
Quantitation of peri-nuclear clustering of GFP-Rab10. (C) Cells were stained with rabbit anti-pRab10 antibody (red)
Figure 3 continued on next page
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detected in RPE cells (Figure 5D). Quantitation of ciliation as a function of RILPL1 expression in RPE
cells showed that the phenotype was strongest in cells showing the highest RILPL1 expression levels
(Figure 5E).
To further study how RILPL1, Rab10 and/or RILPL1/pRab10 complexes suppress ciliogenesis,
GFP-Rab10 or GFP-Rab8A were expressed in A549 cells lacking RILPL1. In this background, exoge-
nous Rab10 inhibited and Rab8A stimulated ciliogenesis, even in the absence of RILPL1 (Figure 5F).
This suggests that Rab8A and Rab10 do not absolutely require RILPL1 for their effects on ciliogene-
sis or can mediate their effects via another protein such as the related RILPL2. In contrast, when
exogenous RILPL1 was introduced into cells lacking Rab8A or Rab10, it was no longer capable of
repressing ciliogenesis (Figure 5G). These experiments demonstrate that RILPL1 needs Rab10 to
repress ciliogenesis, however, exogenous Rab10 can also suppress ciliogenesis independent of
RILPL1 protein (Figure 5D,E). Because cells lacking Rab8A are already poorly ciliated, we cannot dis-
cern further RILPL1-inhibition in this cell background.
It was recently reported that LRRK2 overexpression in HEK293T cells decreases centrosomal
cohesion (Madero-Pe´rez et al., 2018). Since RILPL1 and pRab10 accumulate in the pericentriolar
region, we examined the effect of exogenous RILPL1 on centriolar markers in A549 cells (Figure 5—
figure supplement 1). As noted earlier, exogenous RILPL1 was cytosolic but also enriched at the
mother centriole (Figure 3—figure supplement 1). Its expression was sufficient to trigger an
increase in the distance between mother and daughter centrioles in some cells: specifically, 20% of
A549 cells showed centrioles > 2 mm apart, whereas 48% of cells showed this phenotype upon
RILPL1 expression. However, there was no relationship between RILPL1 expression level and centrio-
lar distance over 3 logs of expression measured by quantitative light microscopy (Figure 5—figure
supplement 1). This indicates that centriolar separation may be a secondary phenomenon, indirectly
triggered in some cells by RILPL1 expression. No change in centriolar distance was detected in
RILPL1 KO cells; finally, the ability of RILPL1 to increase centriole distance was completely nullified in
Rab10 or Rab8A-KO cells while the RILPL1 localization remained unchanged. In summary, RILPL1
blocks ciliation by a Rab10-dependent process and may disrupts centriolar pairs in some cells under
the same conditions.
LRRK2 kinase acts via a pRab10-RILPL1 pathway to inhibit ciliogenesis
We previously reported that mouse embryonic fibroblasts (MEFs) derived from LRRK2-R1441G mice
showed fewer primary cilia, a phenotype that was reversed by adding the LRRK2-specific inhibitor,
MLi2 (Steger et al., 2017). Endogenous pRab10 was detected (for the first time) in R1441G LRRK2
MEF cells localized at the base of primary cilia (Figure 6A). The pRab10 staining was lost on treat-
ment with MLi2 along with a concomitant increase in ciliogenesis (Figure 6A,C). Thus, LRRK2 phos-
phorylated Rab10 is seen concentrated at the base of primary cilia.
To investigate whether pRab10 and RILPL1 contribute to the defect in ciliogenesis observed in
R1441G MEF cells, both proteins were depleted using lentiviral shRNAs. qPCR analysis showed
more than 85% reduction in the levels of both mRNAs upon shRNA expression (Figure 6B). In con-
trol cells, RILPL1 and pRab10 localized to the base of cilia and this staining was lost upon expression
of either of the corresponding shRNAs (Figure 6A). Importantly, when either Rab10 or RILPL1 was
depleted, the effect of LRRK2 activity on cilia formation was completely abolished. These data dem-
onstrate that the ability of pathogenic LRRK2-R1441G to influence cilia formation depends entirely
on the presence of Rab10 and RILPL1 proteins.
Figure 3 continued
and co-stained with either mouse anti-GFP (green), mouse anti-Centrin-3 (green) or mouse anti-transferrin receptor
(TfR, green). (D) HEK293T cells were co-transfected with myc-LRRK2-R1441G and RILPL1-GFP (green). After 24 hr,
cells were fixed and stained for pRab10 (red) and LRRK2 (blue). Dotted lines indicate cell boundaries. Dotted
boxes indicate the enlarged region of interest. Scale bars, 10 mm.
DOI: https://doi.org/10.7554/eLife.40202.007
The following figure supplement is available for figure 3:
Figure supplement 1. RILPL1 localizes to mother centrioles.
DOI: https://doi.org/10.7554/eLife.40202.008
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Figure 4. Localization of pRab10 is influenced by RILPL1. (A) RPE cells were ciliated for 24 hr and stained with rabbit anti-RILPL1 antibodies (red) and
co-stained with mouse anti-Arl13b or rabbit anti-Rab10 antibodies (green). (B) Rat primary astrocytes were ciliated and stained with anti-RILPL1 and
anti-Arl13B antibodies as indicated. (C–E) HEK293T cells were infected with lentiviral shRNA for RILPL1 and selected by puromycin. LRRK2-R1441G was
co-transfected with either RILPL1-WT. Also, RILPL1-C-terminus GFP or RILPL1-N-terminus GFP (green) were co-transfected with LRRK2 in wildtype cells.
After 24 hr, cells were stained with anti-phospho-Rab10 antibody (red). (D) Quantitation of cells with peri-centriolar clustering of pRab10 in RILPL1 knock
down HEK293T cells, with or without rescue by (full length) RILPL1-WT. (E) Quantitation of peri-centriolar clustering of pRab10 in cells transfected with
full length, RILPL1-N terminus, RILPL1-C terminus. (F) A549 WT and A549-RILPL1 knock out cells were transfected with myc-LRRK2-R1441G and 24 hr
later, stained with anti-pRab10 (red) and DAPI (blue). (G) Quantitation of total pRab10 in peri-centriolar clusters. (H) A549 WT and A549-RILPL1 knock
Figure 4 continued on next page
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Figure 6D compares two scenarios by which Rab10 and RILPL1 interfere with cilia formation. At
endogenous levels of expression, we propose that pathogenic LRRK2 generates an inhibitory com-
plex that contains pRab10 and RILPL1. RILPL1 shows enhanced binding to p-Rab10, and our data
show that LRRK2 inhibition requires both of these proteins to yield a ciliation defect. In addition, in
the absence of pathogenic LRRK2, upon overexpression of RILPL1, we also detect inhibition of cilia
formation; this inhibition requires the presence of Rab10, and may reflect a similar inhibitor complex
that requires overexpression to generate in the absence of Rab10 phosphorylation. In addition, over-
expressed Rab10 can also inhibit cilia formation in a RILPL1-independent manner that may involve
RILPL2 or other proteins; RILPL1 appears a more potent inhibitor than Rab10 upon overexpression.
Further work is needed to explore this possibility. In summary, our data support a model in which
pathogenic LRRK2 alters cilia formation by phosphorylating Rab10, which recruits RILPL1 to coordi-
nately interfere with cilia formation (Figure 6D, right). In the absence of LRRK2 activation, exoge-
nous RILPL1 can also block ciliation from its location adjacent to the mother centriole; in this
scenario, RILPL1 requires Rab10 protein (Figure 6D, left). We speculate that additional copies of
exogenous RILPL1 are sufficient to bind non-phosphorylated Rab10 protein to generate a dominant
inhibitor of ciliation.
Pathogenic LRRK2 decreases sonic hedgehog signaling in MEFs and
human iPS cells
How might cilia dysfunction influence Parkinson’s disease pathology? Efficient Sonic hedgehog (Shh)
signaling requires the ability of many cell types to form primary cilia and traffic signaling proteins
such as Smoothened into the primary cilium (Rohatgi et al., 2007; Caspary et al., 2007). Shh signal-
ing triggers a downstream pathway that increases the expression of the Gli1 transcription factor
(Dahmane et al., 1997; Niewiadomski and Rohatgi, 2015). To test whether LRRK2 interference
with ciliogenesis alters the ability of cells to respond to Shh, R1441G-expressing MEF cells were
treated with Shh, with or without the LRRK2 inhibitor, MLi2; the amount of Gli1 transcript produced
was then monitored by qPCR. As shown in Figure 7A, Gli1 expression increased upon addition of
Shh; moreover, inhibition of the LRRK2 kinase in these cells resulted in an almost two fold increase in
the response of these cells to Shh. These experiments show clearly that the ability of LRRK2 to block
cilia formation correlates directly with the ability of LRRK2 expressing cells to carry out Shh signal
transduction.
Similar results were obtained using patient-derived, induced pluripotent stem cells (iPS cells) car-
rying the LRRK2 G2019S mutation (Figure 7B–E). Undifferentiated LRRK2 G2019S iPS cells
(LRRK2G2019S/WT), and the corresponding, zinc finger-corrected wild type cell line (LRRK2WT/WT;
Sanders et al., 2014) were plated on matrigel-coated coverslips and stained for the presence of cilia
after 72 hr. Cells carrying the G2019S mutation showed 50% less ciliation than the corresponding,
corrected iPS cells; the length of the cilia were comparable (Figure 7B,D). Importantly, the extent of
ciliation in the G2019S iPS cells was fully restored upon treatment with MLi2 (Figure 7C). Like their
R1441G LRRK2 MEF cell counterparts, LRRK2G2019S/WT iPS cells showed 50% less Gli1 expression
than wild type cells, and this reduction was directly proportional to the extent of their loss of cilia
(Figure 7C,E). These experiments demonstrate that pathogenic LRRK2 proteins can influence Shh
signaling by changing the extent of ciliation in multiple cell types. That a heterozygous LRRK2
mutant iPS cell line showed this defect was striking.
LRRK2 R1441C mice show cilia defects in the brain
To study further whether primary cilia defects seen in cell culture are also present in the brain, brain
sections from 7 month old, LRRK2 R1441C mutant mice were compared with age- and litter-matched
wild type animals. Sagittally sectioned brain slices were stained with neuron-specific primary cilia
markers: adenylate cyclase 3 (AC3), the major neuron-specific primary cilia marker, and somatostatin
Figure 4 continued
out cells were lysed and analyzed by immunoblotting with the indicated antibodies. Error bars represent SEM from three experiments with >50 cells per
condition in each experiment. *, p<0.05; **, p<0.05; ***, p<0.001. Scale bar, 10 mm.
DOI: https://doi.org/10.7554/eLife.40202.009
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Figure 5. RILPL1 is a negative regulator of ciliation. (A) Quantitation of primary cilia in WT and RILPL1-KO A549 cells. (B) Quantitation of cilia length in
WT and RILPL1-KO cells. (C) Quantitation of cells with cilia when RILPL1-GFP is expressed in WT or RILP1-KO ad A549 cells. (D) Quantitation of cells
with cilia when RILPL1-GFP is expressed in WT hTERT-RPE cells. (E) Quantitation of RILPL1-GFP expression in ciliated versus non-ciliated cells RPE by
determining GFP signal intensity per cell in microscopy images. (F) Quantitation of cilia in A549 RILPL1-KO cells that were either un-transfected or
transfected with GFP alone, GFP-Rab10 or GFP-Rab8A. (G) Quantitation of cilia in A549 cells lacking Rab8A or Rab10 as indicated, with or without
RILPL1-GFP expression.
DOI: https://doi.org/10.7554/eLife.40202.010
The following figure supplement is available for figure 5:
Figure supplement 1. Exogenous RILPL1 expression disrupts centriolar cohesion.
DOI: https://doi.org/10.7554/eLife.40202.011
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Figure 6. LRRK2-mediated cilia defects require Rab10 and RILPL1. Rab10 and RILPL1 were depleted from LRRK2 R1441G MEFs using lentiviral delivery
of shRNA. Cells were plated on coverslips or lysed for qPCR analysis 4 days post-infection. After 48 additional hours, cells were serum starved for 16 hr
in the presence of 200 nM MLi2 or DMSO as indicated. (A) Cilia were stained with anti-Arl13b antibodies (red) and either anti-pRab10 (green) or anti-
RILPL1 (green) as indicated. Nuclei were stained with DAPI (blue). Scale bar, 10 mm. Inset boxes show magnified regions including the cilium and its
base. (B) Relative mRNA expression for Rab10 and RILPL1 in Rab10KD and RILPL1KD normalized to control R1441G-MEF cells. Error bars indicate
standard error of the mean from quadruple qPCR replicates. (C) Quantitation of primary cilia in (left) R1441G-MEF cells or (right-most three bars) WT
MEF cells,±MLi2,±Rab10 knock down or ±RILPL1 knock down. Error bars represent SEM from duplicate experiments quantifying >100 cells per
experiment. Student unpaired 2-tailed T-test values showing *,<0.05, **,<0.001. (D) Graphical representation of the working model in which RILPL1 and
phosphorylated Rab10 suppressing cilia formation cooperatively. RILPL1 cannot inhibit ciliation in cells lacking Rab10; overexpression of Rab10 inhibits
Figure 6 continued on next page
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receptor 3 (SSTR3) that is also found in primary cilia in certain brain regions (Ha¨ndel et al., 1999;
Bishop et al., 2007; Berbari et al., 2008). According to the human protein atlas and
(Mandemakers et al., 2012; West et al., 2014), LRRK2 expression is highest in the cerebellum, hip-
pocampus and cortex (Figure 8G). The majority of the neurons in the cortex, striatum and hippo-
campus (but not the cerebellum) had AC3+ primary cilia. SSTR3+ cilia were found in the cortex and
the hippocampus but not in the striatum, presumably because striatal neurons themselves secrete
somatostatin to signal to other cells.
Primary cilia length and density varied between these brain regions. Consistent with data from
MEF-R1441G and human iPS cells, fewer neurons in the somatosensory cortex of R1441C mouse
Figure 6 continued
ciliation, and LKKR2 kinase increases the susceptibility of cells to RILPL1 inhibition by increasing the affinity of RILPL1 for p-Rab10 protein. Under these
conditions, pRab8A can also bind RILPL1 and both Rab8A and Rab10 fail to bind most of their other effector proteins.
DOI: https://doi.org/10.7554/eLife.40202.012
Figure 7. Ciliary signaling defects in MEFs and patient-derived iPS cells. (A) Confluent LRRK2 R1441G MEF cells were treated with 25 nM Sonic
hedgehog (Shh) or PBS along with 200 nM MLi2 or DMSO for 24 hr under serum starvation conditions and then lysed for RNA isolation. Shown is the
Gli1 mRNA level relative to GAPDH mRNA, normalized to control samples treated with both MLi2 and Shh. Error bars indicate standard error of the
mean from three independent experiments. (B–E) Undifferentiated, patient derived LRRK2G2019S/WT iPS cells were cultured for 48 hr on matrigel coated
coverslips. They were fixed and stained for Arl13b (B) or lysed for RNA isolation and qPCR analysis (E). (B) Arl13b (green) and DAPI (blue) staining in
G2019S or wild type cells as indicated. (C,D) Quantitation of ciliation and cilia lengths for LRRK2WT/WT and LRRK2G2019S/WT iPS cells; MLi2 treatment was
for 24 hr (400 nM). (E) Relative mRNA expression of human Gli1 in LRRK2G2019S/WT iPS cells normalized to LRRK2WT/WT corrected cells as indicated. Error
bars indicate SEM from two independent experiments, each done in duplicate. P values were from Student’s unpaired 2-tailed t test; ns = not
significant, **,<0.01, ****,<0.001.
DOI: https://doi.org/10.7554/eLife.40202.013
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Figure 8. Primary cilia in mouse brain. Brains from wild type and 7 month old R1441C LRRK2 mice were stained with rabbit antibodies to neuron-
specific primary cilia markers: somatostatin receptor 3 (SSTR3) or adenylate cyclase 3 (AC3). Primary cilia were quantified from somatosensory cortex,
Figure 8 continued on next page
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brains had primary cilia compared to wild type brains, detected using anti-SSTR3 and AC3 antibod-
ies (Figure 8A,B). No significant difference was found between R1441C and wild type neurons in
terms of overall cilia lengths in the cortex, hippocampus or striatum (Figure 8D). Cilia densities were
slightly lower in R1441C hippocampus but the differences were not statistically significant (Figure 8—
figure supplement 1).
Choline acetyl transferase (ChAT)-positive cholinergic neurons represent 1–4% of all neurons in
the striatum (Lim et al., 2014). These cholinergic neurons send long-distance projections onto tyro-
sine hydroxylase positive, dopaminergic neurons and also receive signals from them (Threlfell et al.,
2010; Ding et al., 2006). Dopaminergic neurons send Shh signals to nearby striatal, cholinergic neu-
rons that in return, send neuroprotective signals back to the dopaminergic neurons (Gonzalez-
Reyes et al., 2012). In the striatum, the overall ciliation of neurons was not significantly different in
R1441C mice compared with wild type brains (Figure 8F). Importantly, when primary cilia were spe-
cifically monitored for ChAT-positive neurons, there was a striking reduction in the number of cili-
ated cholinergic neurons in R1441C striatum compared to wild type striatum (Figure 8E,F). R1441C
mice had a highly significant cilia defect in cholinergic neurons that was not seen in wild type mice
brains. These data suggest that loss of dopaminergic neurons in LRRK2-mediated Parkinson’s dis-
ease may be a result of defective ciliogenesis in striatal cholinergic neurons, thus impairing a critical
protective loop involving non-cell autonomous Shh signaling between cholinergic and dopaminergic
neurons.
Discussion
We have shown here that Rab8A and Rab10 have opposite effects on ciliogenesis in multiple cell
types: Rab8A stimulates cilia formation, while Rab10 inhibits this process. Rab8A and Rab10 share
numerous effector proteins, and their phosphorylation by pathogenic LRRK2 kinase interferes with
the ability of most of these effectors to interact with the Rabs. However, a few effector proteins,
including RILPL1, bind Rab8A and Rab10 with preference for their phosphorylated forms
(Steger et al., 2017). This unusual class of effectors gains special focus in efforts to understand the
downstream, physiological consequences of hyperactivated LRRK2 kinase that underlies familial Par-
kinson’s disease.
We have shown here that pRab10 colocalizes with its RILPL1 effector on pericentriolar mem-
branes adjacent to mother centrioles, and like Rab10, exogenous RILPL1 expression interferes with
cilia formation. RILPL1 expression leads to more concentrated localization of pRab10 at centro-
somes, consistent with the interaction of these proteins in cells. All of the above mentioned experi-
ments involve exogenous expression of proteins that each may titrate out key players needed for
cilia formation. Importantly, under conditions of endogenous protein expression, pathogenic LRRK2
kinase interferes with ciliation by generating pRab10 that binds endogenous RILPL1 and blocks cilia
formation (Figure 6D). Moreover, LRRK2-mediated ciliation defects were not seen in cells lacking
Rab10 or RILPL1, highlighting the importance of this pathway and these proteins in pathogenic
LRRK2 signaling. How complexes of pRab10 block cilia formation together with RILPL1 protein will
be important to elucidate in the future.
Figure 8 continued
hippocampus and striatal regions. (A) Quantitation of neurons with SSTR3+ primary cilia in the cortex. (B) Percent of total neurons with AC3+ primary
cilia in the cortex. (C) Representative image showing neuronal primary cilia stained for AC3 (red) and nuclei (blue) in the cortex. (D) Average length of
primary cilia in the cortex (mm). (E) Cholinergic neurons in the striatum stained with goat anti-ChAT (choline acetyltransferase antibody, green), anti-AC3
(red) and nuclei (blue). (F) Quantitation of ChAT+ and ChAT- neurons in the striatum with AC3+ primary cilia;>50 cholinergic neurons were counted. (G)
Cartoon depicting the regions in sagittal sections of mouse brains (yellow) where neurons were sampled for primary cilia (left image). Right panel
depicts reciprocal communication between ChAT +neurons in the striatum (green) with tyrosine hydroxylase positive (TH+) dopaminergic neurons
(grey) linked via Glia derived neurotrophic factor (GDNF) and Sonic hedgehog (Shh) signaling. Error bars represent standard error of the mean from
n = 4 mice,>500 cells per mouse; p values were determined by Student’s unpaired 2-tailed t-test.
DOI: https://doi.org/10.7554/eLife.40202.014
The following figure supplement is available for figure 8:
Figure supplement 1. Neuronal primary cilia in hippocampus and striatum.
DOI: https://doi.org/10.7554/eLife.40202.015
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Sato et al., 2014 showed previously that mice lacking Rab8A and Rab8B show normal primary
cilia formation; these mice die, however due to microvillus atrophy caused by failure to correctly
generate these intestinal, apical membranes. Additional knockdown of Rab10 in double-knockout
MEF cells reduced the percentage of ciliated cells in that study. It is important to note Rab8B still
present in our cells may explain the differences in ciliation phenotypes that we have reported here.
How does altering ciliogenesis relate to Parkinson’s disease pathology? Parkinson’s disease is
associated with loss of dopaminergic neurons in the brain. Little is known about primary cilia in the
adult brain; both neurons and astrocytes are ciliated, and they contain typical signaling molecules
that include AC3, SSTR and the Smoothened protein that is important for Shh signaling. We found,
for the first time, that cholinergic neurons in the striatum show cilia defects in R1441C LRRK2 mutant
mice; defects were also seen in the somatosensory cortex, marked by either SSTR or AC3. Kottman
and coworkers (Gonzalez-Reyes et al., 2012) have described a neuroprotective circuit in which Shh
increases the resilience of dopaminergic neurons to toxins that mimic Parkinson’s disease-associated,
dopaminergic neuron loss. Cholinergic neurons of the striatum receive a Shh signal from dopaminer-
gic neurons, which triggers secretion of dopaminotrophic, neuroprotective GDNF. Our data support
a model in which pathogenic LRRK2 in cholinergic neurons impairs their ability to generate cilia,
thereby blocking their receipt of the Shh signal from dopaminergic neurons. This pathway may be
critical for the protection of dopaminergic neurons in aging brains, and represents a mechanism to
explain the selective loss of dopamine neurons associated with the presentation of Parkinson’s
disease.
We cannot yet comment on the status of astrocyte cilia in LRRK2 mutant mice. Anti-AC3 antibod-
ies rarely label astrocytes after postnatal day 10, and Arl13b has been used previously as an astro-
cyte cilia marker (Kasahara et al., 2014). In our hands, mouse anti-Arl13b antibodies labeled cell
bodies and processes of GFAP-positive and negative glial cells but failed to label primary cilia specif-
ically. A possible explanation is that astrocyte cilia are four times shorter than neuronal cilia in rodent
brains and they are deeply recessed into a ciliary pocket, perhaps making them harder to label and/
or detect (Breunig et al., 2008). Additional work will be needed to assess the consequences of path-
ogenic LRRK2 on astrocyte ciliiogenesis throughout the brain.
Finally, it is important to note that LRRK2-mediated familial Parkinson’s disease is quite distinct
from more classic diseases of ciliogenesis called ciliopathies (Reiter and Leroux, 2017). Patients car-
rying mutations in genes critical for cilia formation suffer diverse phenotypes including polycystic kid-
ney disease, retinal degeneration, obesity, skeletal malformations and brain anomalies. Many of
these symptoms are due to critical, developmental defects in Hedgehog and Wnt signaling pro-
cesses that require ciliary pathways for proper signal transduction, even before birth. Because LRRK2
modulates Rab GTPase activity rather than permanently inactivating it, many cell types may have
normal cilia formation or shorter cilia with decreased but still functional signaling capacity. It will be
important to determine which cells and tissues display the greatest cilia defects in LRRK2 models of
Parkinson’s disease, and try to understand how those changes lead to specific loss of dopaminergic
neurons in the brain.
In summary, pathogenic LRRK2 has a profound effect on cilia in cultured cells, and shown here, in
human iPS cells and mutant mouse brains. Loss of ciliation correlates directly with loss of Shh signal
reception in the striatum; other signaling events may also by altered. Olfactory receptor signals
require cilia, and anosmia (loss of smell) is one of the earliest symptoms of Parkinson’s disease.
Future characterization of brain cilia in specific neuronal subtypes will provide critical information
regarding pathways that may be altered in cells expressing pathogenic LRRK2; moreover, ciliation
should be evaluated in cells from patients with idiopathic Parkinson’s disease. Finally, Rab10 expres-
sion levels were reported as significantly increased in Alzheimer’s disease brain
(Alzheimer’s Disease Neuroimaging Initiative et al., 2017), suggesting that Rab10’s role as a cilio-
genesis inhibitor may also be relevant to Alzheimer’s disease pathology.
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Materials and methods
Reagent type
(species)
or resource Designation
Source or
reference Identifiers
Additional
information
Gene
(Homo sapiens)
RILPL1 PMID: 29125462
Gene
(Homo sapiens)
LRRK2 PMID: 2912546
PMID: 29125462
NM_198578.3
Gene
(Homo sapiens)
Rab8a PMID: 29125462
Gene
(Homo sapiens)
Rab10Rab10 PMID: 29125462
Strain, strain
background
(Mus musculus)
B6.Cg-Lrrk2tm1.
1Shn/J mouse,
Jackson Laboratory JAX stock #009346 Tong et al., 2009
Strain, strain
background
(Rattus norvegicus)
SA Sprague
Dawley rat
Charles River Crl:SD/code 400 Foo et al., 2011
Genetic reagent
(shRNA) / (Homo sapiens)
human Rab10 TRCN0000029191
Genetic reagent
(shRNA) / (Homo sapiens)
human Rab8a TRCN0000300539
Genetic reagent
(shRNA) / (Homo sapiens)
human RILPL1 TRCN0000159762
Genetic reagent
(shRNA) / (Mus musculus)
mouse RILPL1 TRCN0000033243
Genetic reagent
(shRNA) / (Mus musculus)
mouse Rab8a TRCN0000100422
Cell line
(Homo sapiens)
A549 Rab8 KO PMID: 29125462
Cell line
(Homo sapiens)
A549 Rab10 KO PMID: 29125462
Cell line
(Homo sapiens)
A549 PMID: 29125462
Cell line
(Homo sapiens)
HEK293T https://mrcppure
agents.dundee.ac.uk/
Cell line
(Mus musculus)
MEF-R1441G https://mrcppurea
gents.dundee.ac.uk/
Cell line
(Homo sapiens)
hTert-RPE ATCC
Cell line
(Homo sapiens)
HeLa ATCC
Cell line
(Homo sapiens)
human iPSC PMID: 24148854 Sanders et al., 2014
Recombinant
DNA reagent
pMCB306-
eGFP-Rab8
PMID: 29125462 Steger et al., 2017
Steger et al., 2017
Recombinant
DNA reagent
pMCB306-
eGFP-Rab10
PMID: 9212815 Purlyte et al., 2018
Recombinant
DNA reagent
pMCB306-
eGFP-LRRK2
PMID: 9212815 Purlyte et al., 2018
Recombinant
DNA reagent
pENTR-2x-
myc-LRRK2
Addgene 25361
Recombinant
DNA reagent
pcDNA5D-
FRT-TO-RILPL1
PMID: 29125462 Steger et al., 2017
Steger et al., 2017
Continued on next page
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Continued
Reagent type
(species)
or resource Designation
Source or
reference Identifiers
Additional
information
Transfected
construct (gRNA)
RILPL1 https://mrcppur
eagents.dundee.ac.uk/
DU57861
Transfected
construct (gRNA)
RILPL1 https://mrcppur
eagents.dundee.ac.uk/
DU57867
Antibody rabbit
monoclonal
anti-RILPL1
Sigma HPA-014314 (1:500)
Antibody rabbit
monoclonal
anti-Rab10
Cell Signaling 8127 (1:1000)
Antibody rabbit
monoclonal
anti-LRRK2
Abcam AB133518 (1:1000)
Antibody rabbit
monoclonal
anti-phospho T73
Rab10
Abcam AB230261 (1:2000)
Antibody rabbit
monoclonal
anti-Rab8
Cell Signaling 6975 (1:200)
Antibody mouse
monoclonal
anti-myc
9E10 clone
hybridoma
(1:1)
Antibody chicken
polyclonal
anti-GFAP
Novus Biologicals NBP1-05198 (1:5000)
Antibody goat polyclonal
anti-choline acetyl
transferase
Millipore AB144P (1:200)
Antibody mouse
monoclonal
anti-Arl13b
Neuromab 75–287 (1:2000)
Antibody mouse
monoclonal
anti-Cep164
Santa Cruz SC-515403 (1:200)
Antibody rabbit
polyclonal
anti-adenylate
cyclase 3
Santa Cruz SC-588 (1:100)
Antibody mouse
monoclonal
anti-NeuN
Biolegend 834501 (1:2000)
Antibody mouse
monoclonal
anti-GFP
Neuromab N86-38 (1:2000)
Chemical
compound,
drug
Lipofectamine
3000
Life Technologies
Chemical
compound,
drug
MLi2 PMID: 29125462
Software,
algorithm
FIJI
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Reagents
MLi2 LRRK2 inhibitor (Scott et al., 2017) was synthesized as described in (Miller et al., 2014). All
DNA constructs and antibodies generated for the experiments are described in (Purlyte et al.,
2018) and can be found at https://mrcppureagents.dundee.ac.uk.
General cloning and plasmids
DNA constructs were amplified in E. coli DH5a and purified using mini prep columns (Econospin).
DNA sequence verification of all plasmids was performed by Sequetech (http://www.sequetech.
com). The following constructs were used: eGFP-Rab8A and eGFP-Rab10 were cloned into lentivirus
vector pSLQ1371 between BstB1 and AvrII sites (Purlyte et al., 2018). Rab8A T72E/A and Rab10
T73E/A were generated by site directed mutagenesis using Pfu polymerase (Agilent Technologies).
eGFP-LRRK2-G2019S was cloned into modified pSLQ1371 with eGFP at the N-terminus. Myc-LRRK2
was obtained from Addgene (#25361) and the R1441G mutation was introduced as described
(Purlyte et al., 2018). RILPL1 was cloned into pcDNA5d/FRT/TO using Gibson assembly and
RILPL1-C and RILPL1-N were made by site directed mutagenesis. Lentiviral shRNA pLKO.1 plasmids
were obtained as bacterial stocks from Sigma: mouse Rab8A (TRCN0000100422), human Rab8A
(RCN0000300539), human Rab10 (TRCN0000029191), mouse Rab10 (TRCN0000335543), mouse
RILPL1 (TRCN0000033243) and human RILPL1 (UTR TRCN0000159762). For human Rab10, pSIH vec-
tor was also used with a GFP reporter. The shRNA sequence for hRab10 5’- GATCCGAAGA
TCAAGCTACAGATCTTCCTGTCAGAATCTGTAGCTTGATCTTCTTTTTG was cloned using EcoRI
and BamHI restriction sites.
Cell culture, transfections and ciliogenesis
HEK293T, HeLa, A549 and hTERT-RPE cells were obtained from ATCC and were cultured in Dulbec-
co’s modified Eagle’s medium containing 10% fetal bovine serum, 2 mM Glutamine, penicillin (100
U/ml)/streptomycin (100 mg/ml) and non-essential amino acids. HEK293T cells were transfected with
Polyethylenimine HCl MAX 4000 (PEI) (Polysciences, Inc.) as described (Reed et al., 2006). RPE and
HeLa cells were transfected with Fugene6 (Promega) while rat astrocytes and A549 cells were trans-
fected using lipofectamine 3000 according to the manufacturer. Cells were checked routinely for
Mycoplasma using either MycoALert Mycoplasma Detection Kit (Lonza LT07-318) or PCR.
Human iPS and rat astrocyte cell culture
Human patient derived G2019S = NM_198578.3 (LRRK2): c.6055G > A (p.Gly2019Ser) iPS cultures
were maintained as described (Sanders et al., 2014). Cells were plated on 4% matrigel coated, 24
well plates. Colonies of iPS cells were dissociated with Accutase, and resuspended in mTesR medium
with 10 mM Y-27632. Cultures of primary rat astrocytes were obtained by antibody panning from rat
pups as described (Foo et al., 2011). In brief, six to ten postnatal Sprague-Dawley rat cortices were
mechanically and enzymatically dissociated to produce single cells. They were passed over succes-
sive, antibody-coated negative panning plates to rid the suspension of microglia, endothelial cells,
and oligodendrocyte precursor cells before selecting for astrocytes with an anti-ITGB5-coated plate.
Astrocytes that attached to the anti-ITGB5-coated plate were trypsinized and plated onto poly-D
lysine coated ACLAR coverslips. Cells were incubated at 37˚C with 10% CO2 and 90% O2 for one to
three weeks.
Lentivirus production
Lentivirus-based shRNA was used for gene knockdown of human Rab8A, mouse/human Rab10,
mouse/human RILPL1 using pLKO or pSIH-GFP vector. The lentiviral vector was co-transfected with
packaging vectors psPAX2, pMD2 VSV-G in HEK293T cells using PEI. pLKO-puro-scramble or pSIH-
GFP-scramble was used as control. After 48 hr, culture supernatants were collected and virus con-
centrated 10x overnight with Lenti-X concentrator (Clontech) according to the manufacturer. Virus
was transduced onto target cells with polybrene (2 mg/ml). To make stable cells, infected cells were
selected with puromycin (0.2–1 mg/ml) 48 hr after infection. Expression of the target protein was ver-
ified by GFP-fluorescence, qPCR and/or immunoblotting.
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Lysis and immunoblotting
Cells were lysed 24 hr after transfection in ice-cold lysis buffer containing 50 mM Tris/HCl, pH 7.5,
1% (v/v) Triton X-100, 1 mM EGTA, 1 mM sodium orthovanadate, 50 mM NaF, 10 mM 2-glycero-
phosphate, 5 mM sodium pyrophosphate, 0.1 mg/ml mycrocystin-LR (Enzo Life Sciences), and EDTA-
free protease inhibitor cocktail (Sigma). Lysates were centrifuged at 13800 x g for 15 min at 4˚C and
supernatants were quantified by Bradford assay (Thermo Scientific) and 60 mg of proteins used for
immunoblotting. Antibodies were diluted in blocking buffer containing 5% milk in 0.05% Tween in
Tris buffered saline (TBS) and incubated overnight on the blots.
Inducing primary cilia
Cells were grown to confluency in DMEM with serum. Mouse embryonic fibroblasts (MEFs) (WT and
R1441G) as well as hTERT-RPE cells were ciliated by overnight serum starvation in DMEM medium
alone. For A549 cells, cells were plated at 80% confluency and 24 hr later, subjected to 2% serum
for 48 hr. Neither rat astrocytes nor iPS cells needed cilia induction. Rat astrocytes made primary cilia
after one week in culture while undifferentiated iPS cells made cilia by 72 hr in culture on matrigel.
To identify primary cilia, cells were stained for cilia markers Arl13b or acetylated tubulin.
Membrane fractionation
Cells were chilled on ice, washed with ice cold PBS, and swelled in 10 mM HEPES pH 7.4. After 15
min, 5X buffer was added to achieve a final concentration of resuspension buffer (50 mM HEPES pH
7.4, 150 mM NaCl, 2 mM MgCl2, 2 mM DTT, 20 mM GDP, 1X protease inhibitor cocktail (Sigma)),
and the suspension was passed 20 times through a 25 gauge syringe. Nuclei were pelleted by centri-
fugation at 1,000 X g for 5 min at 4˚C. The postnuclear supernatant was spun 100,000 X g for 20 min
in a table top ultracentrifuge in TLA100.2 rotor; the resulting supernatant was the cytosol fraction.
Membrane pellets were solubilized in 1% Triton X100 containing 1X resuspension buffer. Protein
was estimated by Bradford assay (BioRad, Richmond, CA). Samples containing 25 mg of membrane
protein, or the equivalent volume of cytosolic protein, were heated at 95˚C for 2 min after addition
of 5X SDS–PAGE sample buffer. Samples were loaded in duplicate onto 12% SDS-PAGE gels for
imunoblotting; filters were incubated with chicken anti-GFP (Aves, 1:2000) overnight then with don-
key anti-chicken 680 (Licor, 1:10,000) for 1 hr, imaged using an Odyssey Infrared scanner (Licor), and
quantified using ImageJ software.
Hedgehog signaling
MEFs were cultured in 24 well plates, and upon confluency, serum starved in DMEM and treated
with 200 nM MLi2 or DMSO. At the same time, cells were treated with either 25 nM Sonic hedgehog
(Shh) or PBS. After 16 hr ± MLi2,±Shh treatment, cells were lysed for RNA extraction and qPCR of
Gli1 mRNA. Human patient derived iPS cells already have high Gli1 levels and did not need Shh
treatment; iPS cells were lysed for qPCR analysis of Gli1 after 72 hr.
Quantitative PCR
To extract total RNA, cells are lysed in Trizol (Sigma) for 5 min in an RNA-free zone. RNA extraction
was performed using chloroform/isopropyl alcohol according to the manufacturer. RNA was stored
at  80˚C. cDNA was synthesized using 500 ng to 1 mg RNA using high capacity cDNA synthesis kit
with multiscribe reverse transcriptase (Applied Biosystems). The cDNA was diluted 50 fold and 1 ml
cDNA was used as template in the PowerUp SYBR green 2X master mix and analyzed in a qPCR
machine (7900HT Applied Biosystems). Gene expression was compared using 2^(delta-delta Ct)
method with GAPDH or Actin as internal controls. The primers used for the qPCR were as follows –
RAB10 HGNC:9759 -fw-GTGGGGAAGACCTGCGTCCTTT, rv- GAGGTTGTGATGGTGTGAAATCGC;
RAB8A HGNC:7007 -fw–CTGGCGAGAGTGAAAAATGC, rv–AAAAGCTGGCCCTCGACTAT; RILPL1
HGNC:26814-fw–ATGGAAGAGGAAAACCGAATACC, rv–AGGCGCTTCTTATCTCGGGA; ACT
HGNC:929-fw–GGCATCCTCACCCTGAAGTA,rv–AGAGGCGTACAGGGATAGCA; HPRT1
HGNC:5157-fw–GGTCAGGCAGTATAATCCAAAG, rv–GGACTCCAGATGTTTCCAAAC; GLI1
HGNC:4317 -fw–GAAGTCATACTCACGCCTCGAA, rv–CAGCCAGGGAGCTTACATACAT; Mus mus-
culus GAPDH-fw–AGGTCGGTGTGAACGGATTTG, rv–TGTAGACCATGTAGTTGAGGTCA; Mus mus-
culus RAB10-fw–GGCAAGACCTGCGTCCTTTT, rv–GTGATGGTGTGAAATCGCTCC; mRILPL1-fw–
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GGTTGCGCGTAGAGAGGATG, rv–CTCACGCTCTGACATGCCTTC; Mus musculus GLI1-fw-
CCAAGCCAACTTTATGTCAGGG, rv- AGCCCGCTTCTTTGTTAATTTGA.
Generation of mutant mice
The LRRK2R1441C/R1441C mice were obtained from The Jackson Laboratory (B6.Cg-Lrrk2tm1.1Shn/J
mouse, JAX stock #009346; Tong et al., 2009) and kept in specific pathogen-free conditions at the
University of Dundee (UK). All animal studies were ethically reviewed and carried out in accordance
with Animals (Scientific Procedures) Act 1986 and regulations set by the University of Dundee and
the U.K. Home Office. Animal studies and breeding were approved by the University of Dundee eth-
ical committee and performed under a U.K. Home Office project license. Mice were multiply housed
at an ambient temperature (20–24˚C) and humidity (45–55%) and maintained on a 12 hr light/12 hr
dark cycle, with free access to food (SDS RM No. three autoclavable) and water. Genotyping of mice
was performed by PCR using genomic DNA isolated from ear biopsies. Primer 1 (5’ -CTGCAGGC
TACTAGATGGTCAAGGT  3’) and Primer 2 (5’ –CTAGATAGGACCGAGTGTCGCAGAG- 3’) were
used to detect the wild-type and knock-in alleles. Homozygous LRRK2-R1441C and littermate wild-
type controls (7 months of age) were used for experiments shown in Figure 8. The genotype of
these mice was confirmed by PCR on the day of experiment.
Generation of knock out A549 cells
A549 Rab8A knockout (Steger et al., 2017) and Rab10 knock-out (Ito et al., 2016) cell lines have
been described (Steger et al., 2017). The A549 RILPL1 knockout cell line was generated using sense
and anti-sense paired guides DU57861 and DU57867 (available at https://mrcppureagents.dundee.
ac.uk), targeting exon 3 of RILPL1; sense guide: GGTGATGAAGAAGCTGAAGG (DU57861); anti-
sense guide: GCTCCCGCTCTGACATGCCT (DU57867). Cells at about 80% confluency were co-
transfected in a six-well plate with the pair of constructs using Lipofectamine LTX reagent (9 ml Lipo-
fectamine LTX and 2.5 mg DNA per well). After 24 hr transfection, the medium was replaced with
medium Supplemented with puromycin (2 mg/ml). After 24 hr selection, the medium was replaced
with medium without puromycin and cells were left to recover for 48 hr before performing single-
cell sorting using an Influx cell sorter (Becton Dickinson). Single cells were placed in individual wells
of a 96-well plate containing DMEM Supplemented with 10% FBS, 2 mM L-glutamine, 100 units/ml
penicillin,100 mg/ml streptomycin and 100 mg/ml normocin (InvivoGen). At about 80% confluency
individual clones were transferred into six-well plates and screened for RILPL1 knock-out by
immunoblotting.
Light microscopy
Cells were plated on collagen coated coverslips transfected with indicated plasmids. Cells were fixed
with 3% paraformaldehyde for 20 min, permeabilized for 3 min in 0.1% Triton X 100 (or 0.1% saponin
for anti-phospho Rab10 antibody staining) and blocked with 1% BSA in PBS. Antibodies were diluted
as follows: mouse anti-Arl13b (1:1000, Neuromab), mouse anti-GFP (Neuromab, 1:1000); mouse
anti-Myc (9E10 Hybridoma culture supernatant – 1:2), rabbit anti-RILPL1 (Sigma, 1:500), rabbit anti-
GCC185 (Cheung et al. 2015, 1:1000), rabbit anti phospho Rab10 (1:1000, Abcam), rabbit anti
adenylate cyclase III (Santa Cruz 1:100), mouse anti-NeuN (Proteintech, 1:1000), goat anti choline
acetyltransferase (Millipore 1:100), rabbit anti Rab8A and Rab10 (1:1000, Cell Signaling), rabbit anti
RILPL1 antibody (Steger et al., 2017), mouse anti tubulin (1:2000, Sigma), mouse anti acetylated
tubulin (1:2000, Sigma), mouse anti Centrin-3 (gift from Tim Stearns, Stanford), chicken anti GFAP
(1:5000, Novus Biologicals), mouse anti Transferrin receptor (1:500, BD Bioscience). Highly cross
absorbed H + L secondary antibodies (Life Technologies) conjugated to Alexa 488, Alexa 568 or
Alexa 647 were used at 1:2000 or 1:4000. All antibody dilutions for tissue staining included 1%
DMSO to help antibody penetration. All images were obtained using a spinning disk confocal micro-
scope (Yokogawa) with an electron multiplying charge coupled device (EMCCD) camera (Andor, UK)
and a 100  1.4 NA oil immersion objective. Images were analyzed using Fiji (https://fiji.sc/) and
whenever necessary, were presented as maximum intensity projections. Nuclei were stained using
0.1 mg/ml DAPI (Sigma).
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In vitro prenylation
For in vitro prenylation, cytosol obtained from membrane fractionation was incubated with 6.7 mM
biotin-geranyl pyrophosphate (Jena Bioscience) for 4 hr, rotating at room temperature. GFP-Rab8A
or GFP-Rab10 were then immunoprecipitated using GFP binding protein immobilized on Sepharose
for 1 hr at 4˚C. Resin was washed 3 times with 1X membrane fractionation resuspension buffer and
eluted with 2X SDS-PAGE sample buffer. The elutions were run on 12% SDS-PAGE gels for immuno-
blotting, detecting prenylation Streptavidin 800 nm (Licor, 1:1000) then chicken anti GFP (Aves
1:2000). Membranes were incubated with donkey anti chicken 680 (Licor 1:10,000) for 1 hr, imaged
using an Odyssey Infrared scanner (Licor0 and quantified using ImageJ software. For Rab8A, dishes
were treated with 10 mM lovastatin 16 hr before lysis—because Rab8A is monoprenylated, this
increased the pool of non-prenylated Rab8A in the cytosol, enabling us to assay for prenylation
capacity in vitro.
Mouse brain processing and primary cilia analyses
Homozygous LRRK2-R1441C and littermate wild-type controls (7 months of age) were terminally
anesthetized and perfused by injection of PBS into the left cardiac ventricle followed by injection of
4% paraformaldehyde in PBS before collecting the brains for analysis. Mice brains were immersed in
30% sucrose for 2 days until they were completely submerged. Brains were then embedded in plas-
tic blocks with OCT (BioTek, USA), frozen on dry ice and stored at  80˚C. While embedding, the
anterior and posterior sides of the brains in the block were noted. For cryosectioning, OCT blocks
were kept at  20˚C for 10 min. The brains were oriented to cut sagittal sections on the cryotome
(Leica CM3050S, Germany) at 16 mm thickness and adhered onto SuperFrost plus tissue slides
(Thermo Fisher, USA). This orientation helped in visualizing cortex, hippocampus and striatal regions
(Figure 8G).
Slices closest to the midline were chosen for immunostaining. For primary cilia staining in brain
sections, frozen slides were thawed at RT for 10 min then gently washed with PBS for 5 min. Sections
were permeabilized with 0.1% Triton X-100 in PBS at room temperature for 15 min. Sections were
blocked with 1% bovine serum albumin and 2% bovine calf serum in PBS for 2 hr at RT. Sections
were incubated overnight with primary rabbit polyclonal antibodies and incubated with secondary
antibodies (Thermo Scientific, 1:1000) at room temperature for 2 hr. Stained tissues were overlayed
with Mowiol and a glass coverslip. Three brain areas were chosen – Somatosensory area of the cere-
bral cortex, pyramidal layer of the hippocampus and striatal area of the caudoputamen, adjacent to
the lateral ventricle. Four to five regions within each brain area were imaged using 0.75 mm Z-sam-
pling for each mouse brain. All image visualizations and analyses were performed using Fiji (https://
fiji.sc). To analyze primary cilia, maximum intensity projections of Z-stacks were median filtered,
thresholded and the resulting mask was subjected to the skeletonize function. Number of Primary
cilia structures in these masks were then counted using Analyze > Analyze Particles. To measure pri-
mary cilia lengths, the output image from the previous step was subsequently analyzed using Ana-
lyze > Skeleton > Analyze Skeleton > Longest shortest path function. The number of nuclei in the
cerebral cortex and striatal regions of the brain were determined by analyzing maximum intensity
projections of the DAPI channel. The image was median filtered, subjected to ‘Fill Holes’, ‘Water-
shed’ followed by Analyze > Analyze Particles. The number of nuclei in the pyramidal layer of the
hippocampus was determined manually by differential pseudo-coloring of the Z-stack to overcome
counting errors caused by tight packing of the nuclei and intense nucleoli staining of neurons in this
region. For cilia analysis of iPS cells, undifferentiated cells were plated on matrigel coated coverslips
and cultured for 72 hr; the cells were subconfluent, two dimensional monolayers rather than organo-
ids. Upon confluency (5 days), they lose their ciliation and were not analyzed further.
Quantitation of centriolar distance
A549 cells transfected with RILPL1-GFP and stained for Centrin-3 or gamma tubulin were imaged on
a confocal microscope with Z-step size of 0.5 mm. Distances were quantified from cells where only
two dots were visible; cells in mitosis were excluded based on nuclear DAPI staining. Only a single
plane from a Z-stack was used to quantify the distance between centrioles to eliminate error intro-
duced by Z-sampling. The distance was measured using FIJI (https://fiji.sc) by drawing a straight line
between the centers of the centriole dots. RILPL1 expression was quantified in FIJI by first
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subtracting background from the sum-intensity projection images, outlining the cells, followed by
measuring the integrated density of the signal from a single cell.
Statistics
Graphs were made using Graphpad Prism six software. Error bars indicate SEM. Unless specified, a
Student’s T-test was used to test significance. Two tailed p-values<0.05 were considered statistically
significant.
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